- Home
- KNSA vs SAM Comparison
KNSA vs SAM Comparison
Compare KNSA & SAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- SAM
- Stock Information
- Founded
- KNSA 2015
- SAM 1984
- Country
- KNSA United Kingdom
- SAM United States
- Employees
- KNSA N/A
- SAM N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- SAM Beverages (Production/Distribution)
- Sector
- KNSA Health Care
- SAM Consumer Staples
- Exchange
- KNSA Nasdaq
- SAM Nasdaq
- Market Cap
- KNSA 2.1B
- SAM 2.1B
- IPO Year
- KNSA 2018
- SAM 1995
- Fundamental
- Price
- KNSA $27.12
- SAM $207.90
- Analyst Decision
- KNSA Strong Buy
- SAM Hold
- Analyst Count
- KNSA 6
- SAM 10
- Target Price
- KNSA $39.33
- SAM $257.11
- AVG Volume (30 Days)
- KNSA 980.0K
- SAM 275.4K
- Earning Date
- KNSA 07-29-2025
- SAM 07-28-2025
- Dividend Yield
- KNSA N/A
- SAM N/A
- EPS Growth
- KNSA N/A
- SAM N/A
- EPS
- KNSA N/A
- SAM 6.16
- Revenue
- KNSA $481,166,000.00
- SAM $2,040,741,000.00
- Revenue This Year
- KNSA $37.21
- SAM $2.69
- Revenue Next Year
- KNSA $5.32
- SAM $2.47
- P/E Ratio
- KNSA N/A
- SAM $33.71
- Revenue Growth
- KNSA 59.45
- SAM 0.79
- 52 Week Low
- KNSA $17.82
- SAM $185.34
- 52 Week High
- KNSA $30.69
- SAM $329.55
- Technical
- Relative Strength Index (RSI)
- KNSA 43.14
- SAM 57.33
- Support Level
- KNSA $28.19
- SAM $189.87
- Resistance Level
- KNSA $29.58
- SAM $199.49
- Average True Range (ATR)
- KNSA 0.93
- SAM 5.86
- MACD
- KNSA -0.13
- SAM 2.40
- Stochastic Oscillator
- KNSA 3.15
- SAM 95.45
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About SAM Boston Beer Company Inc. (The)
Boston Beer is a top player in high-end malt beverages and adjacent categories in the US, with strong positions in craft beer, flavored malt beverages, hard cider, and hard seltzer. The bulk of volume and revenue is concentrated in four brands: Samuel Adams, Angry Orchard, Twisted Tea, and Truly. Beverages are produced using a hybrid model leveraging both in-house capacities and third-party breweries through contract arrangements. While the firm is required to use distributors to reach end markets, including retailers and on-premises operators, it also employs 500 internal sales representatives to educate the market about its products. The firm generates almost all sales in the US.